Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by terr2on Dec 16, 2022 12:52pm
181 Views
Post# 35176147

RE:RE:RE:Very very interesting development

RE:RE:RE:Very very interesting development
  • Therma Bright (THRM) has invested in inhalable statin treatments for respiratory conditions
  • The company signed an agreement with August Therapeutics and Ketiko Bio to acquire a 25-per-cent interest in each of InStatin and InVixa, with an option for increased ownership
  • InVixa and InStatin are developing inhalable statins to treat chronic and acute lung conditions, including COVID-19, asthma and COPD
  • Therma Bright will issue 55 million shares priced at C$0.136364 for total consideration of C$7.5 million
  • The parties anticipate that formal dialogue about the treatments with the FDA will begin in 2023
  • Therma Bright is a medical diagnostic and device technology company
  • Therma Bright (THRM) is down by 14.29 per cent, trading at $0.09 per share.
  • He is the king of dilution. Maybe you should re-read this and tell us all how full of chitt he is. YSC
<< Previous
Bullboard Posts
Next >>